Semaglutide is a synthetic GLP-1 receptor agonist studied for its role in glucose regulation, insulin secretion, appetite signaling, satiety pathways, gastric-emptying effects, body-weight regulation, and broader cardiometabolic health markers.
Potential Human Benefits Being Investigated
- Blood-glucose regulation
- A1C reduction in type 2 diabetes research
- Insulin secretion and insulin-sensitivity pathways
- Appetite and satiety signaling
- Body-weight reduction research
- Weight-maintenance research
- Reduced caloric intake pathways
- Delayed gastric-emptying research
- Cardiometabolic health markers
- Waist-circumference reduction research
- Blood-pressure marker research
- Lipid and cholesterol marker research
